Jiangsu Nhwa Pharmaceutical Co Ltd
SZSE:002262

Watchlist Manager
Jiangsu Nhwa Pharmaceutical Co Ltd Logo
Jiangsu Nhwa Pharmaceutical Co Ltd
SZSE:002262
Watchlist
Price: 26.46 CNY 1.53%
Market Cap: 26.9B CNY
Have any thoughts about
Jiangsu Nhwa Pharmaceutical Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Jiangsu Nhwa Pharmaceutical Co Ltd stock under the Base Case scenario is 31.36 CNY. Compared to the current market price of 26.46 CNY, Jiangsu Nhwa Pharmaceutical Co Ltd is Undervalued by 16%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
31.36 CNY
Undervaluation 16%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Jiangsu Nhwa Pharmaceutical Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Jiangsu Nhwa Pharmaceutical Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Jiangsu Nhwa Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Jiangsu Nhwa Pharmaceutical Co Ltd

Provide an overview of the primary business activities
of Jiangsu Nhwa Pharmaceutical Co Ltd.

What unique competitive advantages
does Jiangsu Nhwa Pharmaceutical Co Ltd hold over its rivals?

What risks and challenges
does Jiangsu Nhwa Pharmaceutical Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Provide P/S
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Provide P/E
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Provide P/OCF
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Provide P/FCFE
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Provide P/B
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Provide EV/S
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Provide EV/GP
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Provide EV/EBITDA
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Provide EV/EBIT
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Provide EV/OCF
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Provide EV/FCFF
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Provide EV/IC
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Show me price targets
for Jiangsu Nhwa Pharmaceutical Co Ltd made by professional analysts.

What are the Revenue projections
for Jiangsu Nhwa Pharmaceutical Co Ltd?

How accurate were the past Revenue estimates
for Jiangsu Nhwa Pharmaceutical Co Ltd?

What are the Net Income projections
for Jiangsu Nhwa Pharmaceutical Co Ltd?

How accurate were the past Net Income estimates
for Jiangsu Nhwa Pharmaceutical Co Ltd?

What are the EPS projections
for Jiangsu Nhwa Pharmaceutical Co Ltd?

How accurate were the past EPS estimates
for Jiangsu Nhwa Pharmaceutical Co Ltd?

What are the EBIT projections
for Jiangsu Nhwa Pharmaceutical Co Ltd?

How accurate were the past EBIT estimates
for Jiangsu Nhwa Pharmaceutical Co Ltd?

Compare the revenue forecasts
for Jiangsu Nhwa Pharmaceutical Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Jiangsu Nhwa Pharmaceutical Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Jiangsu Nhwa Pharmaceutical Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Jiangsu Nhwa Pharmaceutical Co Ltd compared to its peers.

Compare the P/E ratios
of Jiangsu Nhwa Pharmaceutical Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Jiangsu Nhwa Pharmaceutical Co Ltd with its peers.

Analyze the financial leverage
of Jiangsu Nhwa Pharmaceutical Co Ltd compared to its main competitors.

Show all profitability ratios
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Provide ROE
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Provide ROA
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Provide ROIC
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Provide ROCE
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Provide Gross Margin
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Provide Operating Margin
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Provide Net Margin
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Provide FCF Margin
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Show all solvency ratios
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Provide D/E Ratio
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Provide D/A Ratio
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Provide Interest Coverage Ratio
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Provide Altman Z-Score Ratio
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Provide Quick Ratio
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Provide Current Ratio
for Jiangsu Nhwa Pharmaceutical Co Ltd.

Provide Cash Ratio
for Jiangsu Nhwa Pharmaceutical Co Ltd.

What is the historical Revenue growth
over the last 5 years for Jiangsu Nhwa Pharmaceutical Co Ltd?

What is the historical Net Income growth
over the last 5 years for Jiangsu Nhwa Pharmaceutical Co Ltd?

What is the current Free Cash Flow
of Jiangsu Nhwa Pharmaceutical Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Jiangsu Nhwa Pharmaceutical Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Jiangsu Nhwa Pharmaceutical Co Ltd

Current Assets 5.5B
Cash & Short-Term Investments 3.5B
Receivables 1.4B
Other Current Assets 660.8m
Non-Current Assets 2.2B
Long-Term Investments 157.6m
PP&E 1.5B
Intangibles 296.8m
Other Non-Current Assets 206.1m
Current Liabilities 828.7m
Accounts Payable 262.3m
Accrued Liabilities 94.4m
Short-Term Debt 193.7m
Other Current Liabilities 278.3m
Non-Current Liabilities 73m
Long-Term Debt 32.6m
Other Non-Current Liabilities 40.4m
Efficiency

Earnings Waterfall
Jiangsu Nhwa Pharmaceutical Co Ltd

Revenue
5.4B CNY
Cost of Revenue
-1.6B CNY
Gross Profit
3.8B CNY
Operating Expenses
-2.6B CNY
Operating Income
1.2B CNY
Other Expenses
-96.8m CNY
Net Income
1.1B CNY

Free Cash Flow Analysis
Jiangsu Nhwa Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Jiangsu Nhwa Pharmaceutical Co Ltd's profitability score is 66/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Year Average ROIC
Positive Free Cash Flow
Exceptional ROIC
66/100
Profitability
Score

Jiangsu Nhwa Pharmaceutical Co Ltd's profitability score is 66/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Jiangsu Nhwa Pharmaceutical Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Jiangsu Nhwa Pharmaceutical Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Jiangsu Nhwa Pharmaceutical Co Ltd

Wall Street analysts forecast Jiangsu Nhwa Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Jiangsu Nhwa Pharmaceutical Co Ltd is 32.95 CNY with a low forecast of 28.28 CNY and a high forecast of 37.8 CNY.

Lowest
Price Target
28.28 CNY
7% Upside
Average
Price Target
32.95 CNY
25% Upside
Highest
Price Target
37.8 CNY
43% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Jiangsu Nhwa Pharmaceutical Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Jiangsu Nhwa Pharmaceutical Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Jiangsu Nhwa Pharmaceutical Co Ltd Logo
Jiangsu Nhwa Pharmaceutical Co Ltd

Country

China

Industry

Pharmaceuticals

Market Cap

26.3B CNY

Dividend Yield

1.21%

Description

Jiangsu Nhwa Pharmaceutical Co., Ltd. engages in the pharmaceutical production, research and development, and sales. The company is headquartered in Xuzhou, Jiangsu and currently employs 4,732 full-time employees. The company went IPO on 2008-07-23. The firm offers its pharmaceutical products under four categories, which consist of anesthetic medicines, including midazolam injections and etomidate fat emulsion pharmaceutical preparations injections; psychiatric medicines, including risperidone tablets and others; neurological medicines, including gabapentin capsules and others; bulk drugs, including fenofibrate and miconazole nitrate. The firm is also engaged in the pharmaceuticals trading business. Through its subsidiaries, the Company is also engaged in the Internet medical businesses. The firm distributes its products within domestic market and to overseas markets.

Contact

JIANGSU
Xuzhou
Nhwa Technology Mansion, No. 31 Longhu West Road, Economic and Technological Development Zone
+8651687661189
www.nhwa-group.com

IPO

2008-07-23

Employees

4 732

Officers

GM & Non-Independent Director
Mr. Jiaquan Sun
Chief Financial Officer
Mr. Gangsheng Li
Deputy GM & Non-Independent Director
Mr. Ziliang Yang
Deputy GM & Secretary
Mr. Bao Zhou Duan

See Also

Discover More
What is the Intrinsic Value of one Jiangsu Nhwa Pharmaceutical Co Ltd stock?

The intrinsic value of one Jiangsu Nhwa Pharmaceutical Co Ltd stock under the Base Case scenario is 31.36 CNY.

Is Jiangsu Nhwa Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 26.46 CNY, Jiangsu Nhwa Pharmaceutical Co Ltd is Undervalued by 16%.

Back to Top